mbiomics
Decoding the microbiome to redefine therapeutics
$14.12M Series A ·
Source: startupintros.com
Latest round on record: Series A, April 2026, amount undisclosed.
All 2 rounds ↓Signals
Website registeredNov 26, 2020 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | startupintros.com | |
| Series A | $14.12M | — | startupintros.com |
Timeline
- Website created
Founders and team
- JWJohannes Wöhrstein CEO Managing Director Co-Foundersource: mbiomics.com
JB
Johannes B Woehrstein FounderLF
Laura Figulla FounderMR
Markus Rinecker FounderCW
Christopher Weidenmaier Chief Scientific Officer
Investors
Companies like mbiomics
MMicrobiotica$47.69M Series B+ · Oct 2026
MMRM Health$64.12M Series B+ · Sep 2025
EExeliom BiosciencesSeries A · Oct 2025TTheradaptiveSeries A · Jul 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mbiomics (get a free API key).